Laser showdown: which prostate surgery works best?

NCT ID NCT07565961

Recruiting now Symptom relief Sponsor: Ludwig-Maximilians - University of Munich Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two laser surgeries—ThuLEP and HoLEP—for treating enlarged prostate symptoms in men. 150 men will be randomly assigned to one of the two procedures and followed for 12 months. The goal is to see which technique provides better symptom relief, faster recovery, and fewer complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: laser surgery (thulium laser or holmium laser)
What this could lead to: If ThuLEP works as well as HoLEP, it could offer men with enlarged prostate a newer surgical option with similar symptom relief and possibly better bleeding control.
What could go wrong: This is a single-center trial with 150 participants, so results may not apply to everyone. Both procedures are already standard, so this study compares existing options rather than testing a new breakthrough.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BPH (BENIGN PROSTATIC HYPERPLASIA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

benign prostatic hyperplasia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BPH (BENIGN PROSTATIC HYPERPLASIA)

Contacts and locations

Locations

Urologische Klinik und Poliklinik, LMU Klinikum
RECRUITING

Munich, Bavaria, 81377, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.